Susan J. Mack Partner

Ms. Mack’s practice includes all phases of patent prosecution, including, preparing and prosecuting original patent applications, reissue applications and applications for patent term extension.  She handles complex, multiparty interferences and represents clients before the Federal Circuit.  She advises clients on patentability, patent validity, patent infringement, inventorship issues and due diligence matters.  She also prosecutes Plant Variety Protection applications. 

Ms. Mack practices in the chemical and biotechnological arts and, in particular, in the pharmaceutical and agricultural arts.  She has represented clients in the areas of targeted therapeutics, small molecule drugs, protein drugs, gene therapy, immunology, lipid delivery of drugs, nutriceuticals, and genetically altered plants.

District of Columbia
Supreme Court of the United States
U.S. Court of Appeals - District of Columbia, Federal Circuits
U.S. District Court - District of Columbia
District of Columbia Court of Appeals
U.S. Patent and Trademark Office

American University, Washington College of Law (J.D.  1983)
University of Colorado Health Science Center (M.S. Biophysics and Genetics, 1975; NIH Training Grant)
University of Colorado (B.A. Chemistry, Phi Beta Kappa 1972)

Ms. Mack specializes in the technical areas of molecular biology, biochemistry and chemistry, as well as genetic engineering and immunology.


Associations
American Bar Association - Past Chairperson and past co-chairperson for Intellectual Property Committee, USPTO Rules Subcommittee
American Intellectual Property Law Association - Past Liason between women in IP Law and Patent Law Committees
District of Columbia Bar Association - Past Co-chairperson and past steering committee member of the Patent, Trademark & Copyright Law Section
Bar Association for the District of Columbia - Past Chairperson, council member and treasurer of the Patent, Trademark & Copyright Law Section.
Women in Biotechnology - Board member, Chairperson of the Funding Committee, Program Committee member
Intellectual Property Owners Organization - Hatch-Waxman Committee member

Legal
“Finding and Protecting Value in Methods of Treatment and Diagnosis,” Strategic Research Institute, Nanomedicine - commercializing Drug Discovery, delivery & Diagnostics
“Nanotechnology Patent Landscape for Drug Delivery,” Rensselaer Polytechnic Institute, Rensselaer Nanotechnology Center
Patent Resource Group - past lecturer, “Patent Interference Practice; past instructor, “Advanced Patent Application and Amendment Writing Workshop.”
“Submission of Premanufacture Notifications Under the Toxic Substances Control Act,” NGB Corporation, Tokyo, Japan and the Embassies of the United States and Germany.
“Comprehensive Patent Interference Practice,” co-editor (1984 Ed.) (treatise)
"Reform Through Judicial Correction: Anticipating What May Be Next," American Conference Institute, Corporate Patent Congress 2007


Scientific
“A Small RNA Complementary to an Intervening Sequence is Produced Late in SV 40 Infection,” Nature, 291, 334-346 (1981). 
“Leakage of Nuclear Transcripts Late in Simian Virus 40 infected CVI Cells: Quantitation of Spliced and Unspliced Late 19S RNAs,” Journal of Virology, 36, 595-600 (1980).
“Sites of Synthesis of Viral Proteins in Avian Sarcoma Virus - Infected Chicken Cells,” Journal of Virology, 35, 629-636 (1980).
“Early Gene Expression in Bacteriophage T7. I. In Vivo Synthesis, Inactivation, and Translational Utilization of Early mRNAs,” Journal of Virology, 17, 642-658 (1976).
“In Vivo Degradation of Bacteriophage T7 Early mRNAs -- Rates and Determinants,” M.S. Dissertation, Department of Biophysics and Genetics, University of Colorado (1975).